A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
Clinical trial NCT05535920 · COMPLETED
Trial details
- NCT number
- NCT05535920
- Sponsor
- NephroNet, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2024-04-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.